WELCOME TO BIOSENSORS

our news

SUPPORTING PROFESSIONAL EDUCATION AT EuroPcr 2021

May 4,2021 | News | EuroPCR 2021
Visit our Biosensors-NVT industry page and have a look to our latest news and activities during the online course!
READ MORE

TWO-YEAR RESULTS FROM THE BIOMATRIX ALPHA REGISTRY PUBLISHED IN JOURNAL OF INTERVENTIONAL CARDIOLOGY

April 29, 2021 | News | BioMatrix Alpha
MACE 7.2% Cardiac Death 1.3% MI 2.8% & ST 1.1%.
READ MORE

CE Mark Approval for Biolimus A9™ Coated Cobalt Chromium Coronary Stent System BioFreedom™ Ultra

October 19, 2020 | News | BioFreedom™ Ultra
BioFreedom™ Ultra is Biosensors International new, novel thin strut CoCr polymer and carrier-free Drug Coated Stent with Biosensors proprietary limus BA9™, a highly lipophilic anti-restenotic drug, developed specifically for use in coronary vascular applications. BioFreedom™ Ultra successfully extends the LEADERS FREE legacy in LEADERS FREE III.
READ MORE

The 1st DCS/DES approved with 1 month DAPT in High Bleeding Risk patients

December 3, 2020 | News | BioFreedom™ Family
BioFreedom™ since 2015 (CE marked) and now
BioFreedom™ ULTRA is available in CoCr.
READ MORE

The primary endpoint of LEADERS FREE III was presented at PCR e-course 2020

June 27,2020 | News | BioFreedom™ Ultra
The study evaluates the safety and efficacy of the novel thin-strut (84µm) CoCr polymer-free DCS BioFreedom™ Ultra in HBR patients. Details are available in Professor Eberli’s presentation.
READ MORE

BIOSENSORS INTERNATIONAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN NEW PIVOTAL DRUG COATED BALLOON TRIAL "REFORM".

August 11, 2020 | News | Drug-eluting Balloons
The REFORM trial, utilises a Biolimus A9™ coated balloon, the latest development in Biosensors International balloon technology.
READ MORE

INNOVATIVE TECHNOLOGIES

STRUCTURAL HEART

IN COLLABORATION WITH NEW VALVE TECHNOLOGY